Paliperidone Tablet, Extended Release
Product Images NDC 70518-4269

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 70518-4269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Paliperidone extended-release tablets, each containing 3 mg of the active ingredient. The package contains 30 tablets and should be protected from moisture. It is recommended to swallow the tablets whole and not to divide, crush, or chew them. The medication is prescription-only and should be stored at temperatures between 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). The tablets are manufactured by Sun Pharma in Cranbury, NJ and the repackaging is done by RemedyRepack, Inc. in Indiana, PA.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.